nature.com search

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

Search
My Account Login

nature
search

Search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (8)
Correspondence (1)

Journal

Check one or more journals to show results from those journals only.

Modern Pathology (4)
Leukemia (3)
Blood Cancer Journal (1)
Nature Communications (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Hodgkin lymphoma (5)
Pathology (2)
Translational research (2)
Antimicrobial responses (1)
B-cell lymphoma (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–9 of 9 results

Loading Filters

Research | 21 October 2019
Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group
Leukemia 34 , 953–956

Rights & permissionsfor article Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group . Opens in a new window.
Correspondence | 19 August 2019 | Open
Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
- Julia Richter
- , Andreas Hüttmann
- , Jan Rekowski
- , Christine Schmitz
- , Selina Gärtner
- , Andreas Rosenwald
- , Martin-Leo Hansmann
- , Sylvia Hartmann
- , Peter Möller
- , Hans-Heinrich Wacker
- , Alfred Feller
- , Christoph Thorns
- , Stefan Müller
- , Ulrich Dührsen
- & Wolfram Klapper
Blood Cancer Journal 9 , 1–4

Rights & permissionsfor article Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome . Opens in a new window.
Research | 13 December 2018 | Open
Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma
Leukemia 33 , 1463–1474

Rights & permissionsfor article Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma . Opens in a new window.
Research | 23 August 2018
CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma
Modern Pathology 32 , 37–47

Rights & permissionsfor article CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma . Opens in a new window.
Research | 18 May 2020 | Open
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
- Lorenz Thurner
- , Sylvia Hartmann
- , Natalie Fadle
- , Evi Regitz
- , Maria Kemele
- , Yoo-Jin Kim
- , Rainer Maria Bohle
- , Anna Nimmesgern
- , Lutz von Müller
- , Volkhard A. J. Kempf
- , Marc A. Weniger
- , Frank Neumann
- , Nadine Schneider
- , Martine Vornanen
- , Christer Sundström
- , Laurence de Leval
- , Andreas Engert
- , Dennis A. Eichenauer
- , Ralf Küppers
- , Klaus-Dieter Preuss
- , Martin-Leo Hansmann
- & Michael Pfreundschuh
Nature Communications 11 , 1–12

Rights & permissionsfor article Lymphocyte predominant cells detect <i>Moraxella catarrhalis</i>-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma . Opens in a new window.
Research | 14 March 2014
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma
Modern Pathology 27 , 1345–1354

Rights & permissionsfor article A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma . Opens in a new window.
Research | 11 January 2013
Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma
Modern Pathology 26 , 648–657

Rights & permissionsfor article Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma . Opens in a new window.
Research | 10 December 2019
Diagnostic utility of STAT6^YE361 expression in classical Hodgkin lymphoma and related entities
- Charles Van Slambrouck
- , Jooryung Huh
- , Cheolwon Suh
- , Joo Y. Song
- , Madhu P. Menon
- , Aliyah R. Sohani
- , Amy S. Duffield
- , Reva C. Goldberg
- , Paola Dama
- , Kazuma Kiyotani
- , James Godfrey
- , Carrie Fitzpatrick
- , Justin Kline
- , Sonali M. Smith
- , Elaine S. Jaffe
- , Sylvia Hartmann
- & Girish Venkataraman
Modern Pathology 33 , 834–845

Rights & permissionsfor article Diagnostic utility of STAT6<sup>YE361</sup> expression in classical Hodgkin lymphoma and related entities . Opens in a new window.
Research | 28 June 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
- Lorenz Thurner
- , Sylvia Hartmann
- , Natalie Fadle
- , Maria Kemele
- , Theresa Bock
- , Moritz Bewarder
- , Evi Regitz
- , Frank Neumann
- , Anna Nimmesgern
- , Lutz von Müller
- , Christiane Pott
- , Yoo-Jin Kim
- , Rainer Maria Bohle
- , Mariusz Wasik
- , Stephen J. Schuster
- , Martin-Leo Hansmann
- , Klaus-Dieter Preuss
- & Michael Pfreundschuh
Leukemia 33 , 148–158

Rights & permissionsfor article LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting . Opens in a new window.

Advertisement

Search

Article Search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

© 2021 Springer Nature Limited